Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Safety Shot Inc SHOT

Consumer Defensive Household & Personal Products
Safety Shot, Inc. is a wellness and functional beverage company. The Company is launching its Safety Shot, a patented beverage, which reduces blood alcohol content and boosting clarity. Safety Shot is an over-the-counter drink that can lower blood alcohol content to allow recovery from the effects of alcohol at a rate faster than would occur normally. Its product pipeline includes a range of... see more

Recent & Breaking News (NDAQ:SHOT)

SHAREHOLDER ALERT: WeissLaw LLP Reminds JUPW, TMX, CCMP, and MIME Shareholders About Its Ongoing Investigations

PR Newswire January 5, 2022

Halper Sadeh LLP Investigates STXB, GCP, ARNA, JUPW; Shareholders are Encouraged to Contact the Firm

PR Newswire January 5, 2022

JUPITER WELLNESS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Jupiter Wellness, Inc. - JUPW

PR Newswire January 4, 2022

SHAREHOLDER ALERT: WeissLaw LLP Reminds BPMP, SEAC, NEOG, and JUPW Shareholders About Its Ongoing Investigations

PR Newswire December 29, 2021

Halper Sadeh LLP Investigates VRS, BRG, MIME, NPTN, ROG, JUPW; Shareholders are Encouraged to Contact the Firm

PR Newswire December 28, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds NEOG, JUPW, TMX, and TACO Shareholders About Its Ongoing Investigations

PR Newswire December 21, 2021

Moore Kuehn Encourages IMPX, CCMP, FOUN, and JUPW Investors to Contact Law Firm

PR Newswire December 21, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates VRS, GCP, ARNA, JUPW, MIME; Shareholders are Encouraged to Contact the Firm

PR Newswire December 20, 2021

Equity Alert: The M&A Class Action Firm is Investigating the Merger of GSKY, GCP, MPHX, VGII, FLOW, JUPW

PR Newswire December 15, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ARNA, JUPW, GCP, SLRC; Shareholders are Encouraged to Contact the Firm

PR Newswire December 15, 2021

JUPITER WELLNESS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Jupiter Wellness, Inc. - JUPW

PR Newswire December 14, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Jupiter Wellness, Inc.

PR Newswire December 14, 2021

Jupiter (JUPW) Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Jupiter Wellness, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - JUPW

Business Wire December 11, 2021

Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals

Accesswire December 9, 2021

Jupiter Wellness Announces JW-300 Clinical Trial Results

Accesswire November 16, 2021

Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema

Accesswire November 11, 2021

Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics

Accesswire November 3, 2021

Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns

Accesswire October 19, 2021

Jupiter Wellness Provides Shareholder Update on Multiple Clinical & Commercial Milestones

Accesswire October 7, 2021

Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els

Accesswire September 8, 2021